UAE Health Ministry Clears Merck's Juvicor For Treating Type 2 Diabetes
This article was originally published in PharmAsia News
Executive Summary
The United Arab Emirate's health ministry approved Merck's Juvicor (sitagliptin/saxagliptin) combination diabetes drug expected to be used to treat the 18% of the federation's population with the Type 2 form.